Patient-reported outcomes from the randomized phase 3 CROWN study of first-line lorlatinib versus crizotinib in advanced ALK-positive non-small cell lung cancer
Titel:
Patient-reported outcomes from the randomized phase 3 CROWN study of first-line lorlatinib versus crizotinib in advanced ALK-positive non-small cell lung cancer
Auteur:
Mazieres, Julien Iadeluca, Laura Shaw, Alice T. Solomon, Benjamin J. Bauer, Todd M. de Marinis, Filippo Felip, Enriqueta Goto, Yasushi Kim, Dong-Wan Mok, Tony Reisman, Arlene Thurm, Holger Polli, Anna M. Liu, Geoffrey